GSK Aktie
| 21,41EUR | -0,07EUR | -0,33% |
WKN DE: A3DMB5 / ISIN: GB00BN7SWP63
Diese Analysten bewerten die GSK-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Deutsche Bank AG | 20,00£ | 8,84% | 02.09.26 | |||
| JP Morgan Chase & Co. | 17,00£ | -7,48% | 01.09.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 20,00£ | 8,84% | 17.08.26 | |||
| Jefferies & Company Inc. | 25,00£ | 36,05% | 11.08.26 | |||
| Bernstein Research | 30,10£ | 63,81% | 03.08.26 | |||
| UBS AG | 19,40£ | 5,58% | 13.07.26 | |||
| Goldman Sachs Group Inc. | 18,90£ | 2,86% | 30.06.26 | |||
| Barclays Capital | 19,00£ | 3,40% | 30.06.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|